Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.

Abstract

BACKGROUND:

MicroRNAs are involved in hepatocellular carcinoma metastasis, a principal cause of hepatocellular carcinoma-related death in patients worldwide. MiR-212 is a microRNA that has been identified in several types of cancers and is postulated to influence cell signaling and subsequent malignant pathogenesis. Despite emerging reports suggesting that miR-212 plays a significant role in the onset, progression, and migration of these types of malignant tumors, its involvement in the development of hepatocellular carcinoma has not been fully elucidated.

MATERIALS AND METHODS:

Quantitative reverse transcription polymerase chain reaction, wound healing, transwell migration and invasion assays, Western blotting, and xenograft tumor growth models were performed to test the expression levels and functions of miR-212 in hepatocellular carcinoma. Luciferase reporter assay, quantitative reverse transcription polymerase chain reaction, Western blotting, and immunohistochemistry were used to identify and verify the target of miR-212.

RESULTS:

In this study, we identify significant repression of miR-212 in hepatocellular carcinoma and demonstrate that overexpression of miR-212 inhibits the migration of hepatocellular carcinoma cells in vitro and in vivo. Furthermore, we identify forkhead box M1, whose expression is inversely related to that of miR-212, as a direct target of miR-212. Additionally, reexpression of forkhead box M1 rescues the miR-212-mediated inhibition of cell migration. We observed that inhibition of miR-212 activates forkhead box M1 but inhibits the Wnt/β-catenin pathway by suppressing Wnt, LEF-1, c-Myc, and nuclear β-catenin. Finally, in vivo studies confirmed the inhibitory effect of miR-212 on hepatocellular carcinoma growth.

CONCLUSION:

Our present findings indicate that miR-212 is a potential prognostic biomarker of hepatocellular carcinoma and that the miR-212/forkhead box M1 regulatory axis may represent a new therapeutic objective for hepatocellular carcinoma treatment.

• Authors: Pengbo Jia, Guangbing Wei, Cancan Zhou, Qi Gao, Yunhua Wu, Xuejun Sun, Xuqi Li
• Journal: Technology in cancer research & treatment (Technol Cancer Res Treat) Vol. 17 Pg. 1533034618765221 (01 01 2018) ISSN: 1533-0338 [Electronic] United States
• PMID: 29618288 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• 3' Untranslated Regions
• MIRN212 microRNA, human
• MicroRNAs

Topics

• 3' Untranslated Regions
• Animals
• Carcinoma, Hepatocellular (genetics, metabolism, pathology)
• Cell Line, Tumor
• Cell Movement
• Cell Proliferation
• Cell Transformation, Neoplastic (genetics, metabolism)
• Disease Models, Animal
• Gene Expression Regulation, Neoplastic
• Genes, Reporter
• Humans
• Liver Neoplasms (genetics, metabolism, pathology)
• Mice
• MicroRNAs (genetics)
• RNA Interference
• Wnt Signaling Pathway
• Xenograft Model Antitumor Assays